David Ludden, MD
Cardiovascular Disease · la Crosse, WINPI 1073773834
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $55,200 of the $58,736 with a category attached, or 94.0%. Medical Device Business Services, Inc. accounts for 73.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $33,140 and has fallen 62.2% since, to $12,538 in 2025. Among cardiovascular disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $917.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$43K
- Biosense Webster, Inc.$13K
- Medtronic$2K
- Abbott$172
What the payments were for
- Consulting fees$55,20094%
- Travel & lodging$8681%
- Food & beverage$2,6685%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 21 | $43,365 |
| Biosense Webster, Inc. | 14 | $12,869 |
| Medtronic(2 entities) | 27 | $2,331 |
| Abbott | 2 | $172 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$55,717
- Micra$769
- Carto 3 System$191
- SelectSecure$116
- OCTARAY MAPPING CATHETER$110
- Adapta$103
How this compares
$58,736 in reported general payments places this provider in the 95th percentile of 322 cardiovascular disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $24,324 |
| Metoprolol Succinate | 46 | $831 |
| Mupirocin | 41 | $646 |
| Amiodarone Hcl | 17 | $639 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in la Crosse
- Qiying Daila Crosse$9K
- Subhashish AgarwalBrookfield$378K
- Lee BibloMilwaukee$280K
- David GrambowMilwaukee$267K
- Joshua LibermanMequon$230K
- Imdad AhmedJanesville$164K
- David MurdockWausau$164K
- Eric RobertsMilwaukee$131K
- Renuka JainMilwaukee$131K
- Evgenia RaichlinMilwaukee$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.